DEV SITE ..48
5 Ways Ireland is an Attractive Location for Biopharma Companies

5 Ways Ireland is an Attractive Location for Biopharma Companies

Biopharma is a buoyant industry in Ireland and it is growing from strength-to-strength with approx.  20 biologics manufacturing sites operating in Ireland. In the last decade there has been capital investment in the region of $10 billion in new facilities. This represents close to the biggest wave of investment in new BioTech facilities anywhere in the world.

The biopharma sector is forecast to add 8,400 new jobs up to 2020. 

Some of the big biopharma companies based in Ireland include: MSD, Eurofins, Amgen, Takeda and Bristol-Myers Squib.

Did you know . . .

Ireland is a world leader in biopharma

  • 10 of the top 10 world’s pharmaceutical companies are located here.
  • Ireland is the 7th largest exporter of medicinal and pharmaceutical products in the world (2014).
  • Ireland’s total biopharma exports in 2017 was €67.8bn
  • 75 Pharmaceutical companies operate in Ireland
  • 40 FDA (Food and Drug Administration) approved companies in Ireland

 

5 Ways Ireland is an Attractive Location for Biopharma Companies

Ireland is an attractive location for biopharma companies due to our talent pool, educated workforce, our history of success in the sector, adherence to high standards and investment in research.

Talent: Ireland has one of the youngest and most highly educated populations in Europe. This provides a rich and strong pool of talent for the sector, which continues to benefit from high levels of investment in third-level education and the growth of collaborative clusters.

Education: Ireland’s universities in the fields of Engineering, Chemistry, Bio Chemistry and Bio Technology have strong cooperative links with the sector. Feedback from the industry in terms of its skills needs feeds directly into the universities and drives Ireland’s pursuit of Biopharmaceutical academic excellence.

 

Track Record: Manufacturing excellence in Biopharmaceuticals is a hallmark of Ireland's success in the sector. This is constantly driving growth in the likes of Bio Tech, which has developed from two manufacturing sites in 2003 to 18 in 2017.

Excellent Standards: Ireland’s regulatory track record is excellent and the Health Product Regulatory Authority (HPRA), boasts an international reputation in regulatory compliance.

Research: Ireland’s regulatory track record is excellent and the Irish Medicines Board, recently rebranded as the Health Product Regulatory Authority (HPRA), boasts an international reputation in regulatory compliance.

If you would like to learn more about careers in the biopharma sector click here.

For expert advice in this sector from Biopharmachem Ireland click here, you will find career opportunities, employer insights and global opportunities and lots more advice.

The CareersPortal Team

 

 

The CareersPortal Team

Close